CA Stock MarketDetailed Quotes
CLAS Claritas Pharmaceuticals Inc
- 0.000
- 0.0000.00%
15min DelayMarket Closed Jul 12 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.03552wk High0.00%Turnover Ratio36.59MShares0.02552wk Low-0.165EPS TTM0Float Cap420.000Historical High0.00P/E (Static)32.29MShs Float0.025Historical Low0.207EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
Claritas Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | (Q1)Mar 31, 2020 | (FY)Dec 31, 2019 | (Q4)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -205.24%-281K | 306.06%136K | -1,146.15%-324K | 95.23%-309K | -212.26%-484K | 123.99%267K | 98.49%-66K | 96.89%-26K | -33.73%-6.48M | 81.07%-155K |
| Net income from continuing operations | -169.36%-2.62M | 106.67%858K | -116.50%-2.3M | 119.85%4.21M | 92.29%-654K | 487.19%3.78M | -139.98%-12.86M | 318.06%13.94M | -405.87%-21.21M | -822.04%-8.48M |
| Operating gains losses | ---- | ---- | ---- | -337.08%-2.76M | ---- | ---- | ---- | ---- | 95.58%-631K | ---- |
| Asset impairment expenditure | ---- | ---- | ---- | -53.96%15.63M | ---- | ---- | ---- | ---- | 1,198.74%33.95M | 284.32%10.48M |
| Unrealized gains and losses of investment securities | 37.85%-762K | 65.45%771K | 98.03%-39K | ---- | ---- | -61.10%-1.23M | 215.63%466K | -701.22%-1.98M | ---- | ---- |
| Remuneration paid in stock | 836.11%337K | -86.71%19K | -107.80%-11K | -76.65%216K | -152.26%-104K | -86.86%36K | -17.82%143K | -49.28%141K | 5.71%925K | -29.93%199K |
| Other non cashItems | --74K | --77K | 100.93%114K | 20.36%-12.04M | -281.95%-12.3M | ---- | ---- | -341.67%-12.22M | -617.66%-15.12M | -179.92%-3.22M |
| Change In working capital | 204.50%2.69M | -4,081.58%-1.59M | 2,049.44%1.91M | -26.68%-5.57M | -558.67%-3.04M | -322.37%-2.58M | 99.38%-38K | 184.76%89K | -493.29%-4.39M | -41.69%663K |
| -Change in receivables | 1,197.14%384K | -578.57%-95K | -3,800.00%-185K | -121.30%-85K | -105.78%-41K | 45.31%-35K | 90.79%-14K | 105.32%5K | 197.79%399K | 335.55%709K |
| -Change in prepaid assets | ---- | ---- | ---- | ---764K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Change in payables and accrued expense | -160.33%-630K | 2,107.69%574K | -11.76%30K | 102.90%11K | 177.82%193K | -134.77%-242K | 102.05%26K | -92.29%34K | -121.08%-379K | -115.20%-248K |
| -Change in other current assets | ---- | ---- | 4,068.85%2.54M | ---- | ---- | ---- | ---- | 110.46%61K | ---- | ---- |
| -Change in other current liabilities | ---- | ---- | ---- | -24.88%157K | ---- | ---- | ---- | ---- | 494.34%209K | ---- |
| -Change in other working capital | ---- | ---- | -4,218.18%-475K | -5.67%-4.88M | -36,842.86%-2.59M | ---- | ---- | -108.40%-11K | -2,000.91%-4.62M | 95.04%-7K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -205.24%-281K | 306.06%136K | -1,146.15%-324K | 95.23%-309K | -212.26%-484K | 123.99%267K | 98.49%-66K | 96.89%-26K | -33.73%-6.48M | 81.07%-155K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 6K | -3K | |||||
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | --0 | --6K | ---3K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | --0 | --0 | ---- | ---- | --0 | --6K | ---3K | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.53%1K | 73.53%118K | 347K | -57.77%212K | -98.66%68K | 0 | ||||
| Net issuance payments of debt | --0 | --118K | ---10K | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | --1K | --0 | --357K | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.53%1K | 73.53%118K | --347K | ---- | ---- | -57.77%212K | -98.66%68K | --0 | ---- | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | 2,463.64%282K | 833.33%28K | -84.38%5K | ---- | ---- | -98.66%11K | -97.89%3K | -85.90%32K | ---- | ---- |
| Current changes in cash | -158.46%-280K | 3,075.00%254K | 179.31%23K | ---- | ---- | 160.56%479K | -98.82%8K | 65.88%-29K | ---- | ---- |
| End cash Position | -99.59%2K | 2,463.64%282K | 833.33%28K | ---- | ---- | 1,480.65%490K | -98.66%11K | -97.89%3K | ---- | ---- |
| Free cash from | -205.24%-281K | 306.06%136K | -1,146.15%-324K | 95.23%-309K | -212.26%-484K | 123.99%267K | 98.49%-66K | 96.89%-26K | -33.73%-6.48M | 81.07%-155K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg